Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


ATAGI meets on AZ clot issue

Posted 7 April 2021 AM

Acting Chief Medical Officer Michael Kidd has hinted further details of investigations into blood clot concerns with AstraZeneca's Covid vaccine will likely be revealed later today (Wednesday).

Dr Kidd said the Australian Technical Advisory Group on Immunisation (ATAGI) is expected to meet again today after releasing a statement on Good Friday which included recommendations for healthcare providers on a specific clotting condition being reported after vaccination with AstraZeneca's Covid vaccine.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas